🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The OMS/DES study is a multinational European Trial for Children with the O...
Status
Completed
Location
St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE
Start Date
2013-04-18
Trial ID
NCT01868269
Treatments Being Tested
The purpose of this study is to determine whether rituximab is effective in...
Status
Completed
Location
Cochin Hospital
Start Date
2013-04-09
Trial ID
NCT01748084
Treatments Being Tested
This study included patients with glomerulonephritis who planned to receive...
Status
Unknown
Location
Changhai Hospital
Start Date
2023-02-01
Trial ID
NCT05761938
Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Status
Recruiting
Location
Singapore General Hospital
Start Date
2024-12-26
Trial ID
NCT07775235
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815